Metastasen medulläres Nierenkarzinom
Predictive
role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition. Axial CT demonstrating interval improvement in the metastatic lung lesions in patient 1 after 5 cycles of Nivolumab. a Left lower lobe nodule #1 prior to Nivolumab. b Left lower lobe nodule #1 after Nivolumab. c Left lower lobe nodule #2 prior to Nivolumab. d Left lower lobe nodule #2 after Nivolumab
Predictive
role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition. PET scan of patient 1 demonstrating disease progression. a Scan obtained in October 2016 showing prominent mediastinal lesions. b Latest scan in February 2017 after 28 cycles of nivolumab and palliative radiation to the mediastinum showing new metastatic lesions in the liver and lungs but resolution of medistanial disease
Assoziationen und Differentialdiagnosen zu Metastasen medulläres Nierenkarzinom: